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ABSTRACT
Shoulder pain represents one of the 
most frequent clinical conditions in 
the general population and it can be 
generated by a large spectrum of pa-
thologies. The most frequent approach 
of most rheumatologists to shoulder 
pain, in daily clinical practice, mainly 
based on their personal experience, is 
to locally inject drugs. Since the litera-
ture on this topic provides conflicting 
results due to the wide heterogene-
ity in the study designs, we decided to 
report the most relevant studies. Not 
enough data are available to assess 
whether US-guided injections are more 
efficient in controlling shoulder pain 
with respect to the landmark approach. 
However, it is likely that US-guided 
technique shows a more rapid improve-
ment, possibly by providing a higher 
corticosteroid volume injected right 
where it is needed. When injecting hya-
luronic acid, a more accurate localisa-
tion of the medicament might be useful 
to improve efficacy and avoid adverse 
effects (i.e. pain), however, there are no 
studies comparing the blind approach 
to the US-guided one. Finally, new 
treatments for shoulder pain have been 
used but they still need future valida-
tion in more appropriate RCTs.
Introduction
Shoulder pain represents one of the 
most frequent clinical conditions in the 
general population, with a prevalence 
ranging from 7% to 10% in different 
studies (1) and it can be generated by 
a large spectrum of pathologies, related 
to the complexity of this anatomic site, 
involving joints, tendons and bursae, 
which frequently overlap. Different 
approaches to shoulder pain have been 
applied by rheumatologists in daily 
clinical practice (i.e. systemic and/or 
local drugs administration, physical 
therapy or their combinations), mainly 
based on the personal experience of the 
physician. In fact, the scientific evalu-
ation of the efficacy of different kinds 
of treatment has produced conflicting 
results, which are the natural conse-
quence of the wide heterogeneity in the 
study designs. The diagnosis and the 
monitoring of the efficacy have been 
obtained using methods with differ-
ent sensitivity, such as questionnaires, 
physical examination or imaging mo-
dalities (x-ray, ultrasound, MRI), at 
different times (short- or long-term 
monitoring). Moreover, both local and 
systemic factors may affect in different 
ways the subjective improvement re-
ferred by patients after an injection for 
shoulder pain. In fact, specific shoulder 
conditions could influence response 
to the corticosteroid (CS) injection in 
varying degrees (i.e. acute inflamma-
tion might be more likely to respond 
to injections than conditions such as 
rotator cuff tears or long-standing de-
generative joint disease), and patients 
with active inflammatory arthritis may 
experience a benefit from CS injection 
independently of their shoulder pathol-
ogy (2). Shoulder pain can also resolve 
spontaneously and local injection has a 
significant placebo effect (3-5). Even if 
it has been demonstrated that CS works 
better than oral non-steroidal anti-in-
flammatory drugs (NSAIDs) in reduc-
ing pain, increasing active abduction 
and improving functional limitation in 
patients with rotator cuff tendonitis (6), 
conflicting results were obtained com-
paring CS plus lidocaine to lidocaine 
alone (in subacromial impingement 
syndrome patients) (7-8). No definite 
results are provided regarding the dose 
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of CS to inject (triamcinolone aceton-
ide 40 mg failed to be more effective 
with respect to 20 mg) (9) and whether 
a local or systemic injection is the most 
effective (no differences between ul-
trasound (US)-guided CS injection in 
the subacromial bursa and gluteal in-
jections for improvement in the over-
all shoulder pain and disability index 
score) (10). 
Furthermore, in the case of the local 
injection therapy, the procedure can 
be performed using the anatomic land-
marks (blinded) or guided-methods 
(fluoroscopy or ultrasound). In the 
last decade, the US-guided approach 
has been chosen by a large number of 
rheumatologists attracted by the oppor-
tunity to obtain higher rates of correct 
placement of the medication (much less 
than 50% of the blind injections are ac-
curately placed (11)). Even if there is 
not a unequivocal literature supporting 
the fact that this goal always means 
higher efficacy than the blinded proce-
dures, especially for soluble drugs such 
as CS (12), it is reasonable to hypoth-
esise that a higher level of accuracy 
could imply a higher degree of safety. 
Another relevant advantage of the US-
guided procedure is that the approach 
can be tailored to the patient, after a 
preliminary US evaluation, according 
to the most suitable insertion site for 
both the patient and the operator, thus 
reducing the risks (i.e. neuro-vascular 
bundle contact) and the patient’s dis-
comfort. Finally, while the clinically 
oriented procedures are, paradoxically, 
based on normal anatomy, US-guided 
injections can be strictly personalised 
according to the pathologic condition. 
Injection in the shoulder area could 
allow the administration of different 
drugs or substances: anesthetics, CS, 
hyaluronic acids (HA) and new drugs. 
The first group is not the field of the 
rheumatologist, however, there is a 
great deal of literature dealing with this 
and more than 90 papers are actually 
present in PubMed. US guidance, in 
that case, is used to reach the diffusion 
areas, typically around vessels, possi-
bly minimising the dose of the drug. 
The other groups are the main interest 
for rheumatologists and those will be 
discussed in this review.  
Materials and methods
Search strategy
The search for relevant papers was per-
formed using the electronic databases 
MEDLINE (PubMed) and EMBASE, 
as well as a manual search of the ab-
stracts accepted at the EULAR and 
ACR meetings held in 2012. No lan-
guage or publication restrictions were 
applied at this step. Two strings of re-
search were used in MEDLINE (Pub-
Med) with different sensitivities: 
•	 ( “Shou lde r /u l t r a sonography” 
[Mesh]) OR “Shoulder Pain/ultra-
sonography” [Mesh]) OR “Shoulder 
Impingement Syndrome/ultrasonog-
raphy” [Mesh]) OR “Bursitis/ultra-
sonography” [Mesh]) AND “Injec-
tions” [ Mesh]. 
•	 (“shoulder” [MeSH Terms] OR 
“shoulder” [All Fields]) AND (“ul-
trasonography” [Subheading] OR 
“ultrasonography” [All Fields] OR 
“ultrasound” [All Fields] OR “ultra-
sonography” [MeSH Terms] OR “ul-
trasound” [All Fields] OR “ultrason-
ics” [MeSH Terms] OR “ultrason-
ics” [All Fields]) AND (“injections” 
[MeSH Terms) OR “injections” [All 
Fields] OR “injection” [All Fields])
The search in the EMBASE electronic 
database was made both using the em-
tree and free language. The search was 
meant to be quite broad, to be more sen-
sitive than specific, and was last carried 
out on May 23rd, 2013.
Eligibility criteria
After completion of the search, all ran-
domised controlled trials referring to 
ultrasound-guided injections into the 
shoulder were included in the review, 
while papers referring to paediatric, 
animal and cadaver studies as well as 
articles published in languages other 
than English, French or Italian were 
now excluded.
Study selection 
The titles of all of the papers were ex-
amined and the abstracts read. In the 
case of eligibility, the full-text article 
was retrieved and assessed. In the end, 
the ones considered to be suitable (RCT 
involving US-guided injections of CS 
and HA in the shoulder) were included 
in the review. We also included studies 
on other substances, to report what the 
future direction of the research could 
be.
Results
The search strategy identified a total of 
514 records: 222 papers in the electron-
ic databases MEDLINE (PubMed) (24 
using MESH string and 215 using only 
the boleian connector “AND”, with 17 
duplicate titles) and 292 in EMBASE 
(48 records from the em-tree and 301 
from the free language, with 57 dupli-
cate titles). After duplication screen-
ing, 303 records remained. The manual 
search of the abstracts accepted at the 
EULAR and ACR meetings yielded 
3 records in the EULAR and 1 in the 
ACR 2012 meeting. Figure 1 shows the 
selection process and the final result. 
The search also retrieved the system-
atic review already published (13-15). 
The main point arising from the reading 
of the papers is that a relevant degree 
of variability is detectable between the 
studies. In fact all of the studies differ 
in many important points (i.e. design, 
patients enrolled, drug used, etc.). For 
this reason, we decided to report only 
the most relevant studies without mak-
ing any meta-analysis, while trying to 
give the reader most of the information 
available to decide whether and when 
to use the US-guided technique.
CS injection
Strong evidence supporting the US-
guided approach or the blind approach 
is lacking, mainly due to the design of 
the studies published. In some studies, 
the US and blind approaches cannot be 
compared because of the different dis-
eases or targets to inject in the patients 
enrolled. 
Recently, at least three systematic re-
views have investigated the field of 
US-guided vs. blind approach CS in-
jections in the shoulder (13-15): one of 
those, a particularly exhaustive review, 
concluded that there were no signifi-
cant differences (14), two demonstrat-
ed significant but minimal US-guided 
approach superiority (13, 15).
Some papers are included in all of those 
systematic reviews (2, 16), while some 
others are included in two of them (17-
18) or just in a single review (19-21), 
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irrespective of the date of publication. 
Given the fact that we are not making 
any meta-analysis, we report all of the 
RCTs that may give the data needed to 
clarify whether US-guided procedures 
are providing better results with re-
spect to blind injection.
Naredo et al. first published an interest-
ing paper on a RCT comparing blind 
injection vs. US-guided injection of lo-
cal CS in patients with painful shoulder 
(16). They included different causes of 
acute pain (impingement, rotator cuff 
tear, subacromial-subdeltoid bursitis, 
biceps tenosynovitis, while previous 
trauma or chronic inflammatory arthri-
tis were excluded) and different injec-
tion approaches. The lateral approach, 
directed at the subacromial-subdeltoid 
bursa, was used for the blind injection 
(group 1), while the US-guided pro-
cedure was both directed at the bursa 
and the biceps tendon (depending on 
where the effusion was localised) or 
peri or intralesional when rotator cuff 
calcifications were found (respectively 
in 14, 3 and 4 patients) (group 2). In 
the end, only 14/21 of the group 1 re-
ceived a similar injection (at least aim-
ing at the same point) with respect to 
the 20/20 of the first group. The results 
on pain (VAS 0–100) and function 
(Shoulder Function Assessment [SFA]) 
were given comparing the whole group 
1 to the whole group 2. A significantly 
greater improvement in SFA and VAS 
scores was demonstrated at six weeks 
for group 2. Needle placement was ac-
curate in all of the patients of group 2 
while only in 3/20 in group1 (plus 3 
others where CS was positioned both 
in the bursa and deltoid muscles).
A few years later, Ucuncu et al. pub-
lished a new RCT comparing US- to 
landmark-guided injections for shoul-
der pain (2). The authors included 
in the same group patients with very 
different shoulder pathologic condi-
tions (acromioclavicular degeneration, 
rotator cuff lesions – considering full 
or partial rupture, tendinosis, impinge-
ment, calcification – effusion in biceps 
tendon, partial tear of biceps tendon, 
bursitis) and they were not randomised 
according to the real cause of the dis-
ease. Besides, again, blind injection 
used the lateral approach in the sub-
acromial region, while the US-guided 
ones were administered perilesionally 
or intralesionally, so using a different 
anatomical approach. Thirty patients 
were allocated to group 1 (landmark-
guided injection) and the same number 
to group 2 (US-guided injection), and 
no significant differences were found 
in the composition of the two groups. 
A significantly better improvement in 
Constant scale, in ROM and a decrease 
in pain (VAS score) was demonstrated 
in group 2.
In 2006, Chen et al. published a two-
arm controlled clinical trial in 40 pa-
tients with subacromial bursitis (17). 
In this study, all the patients had a US 
examination performed prior to the 
procedure and effusion in the bursa 
was assessed. The needle was moved 
trying to aspirate the effusion before 
the injection in both groups. The shoul-
der abduction range after one week was 
the primary outcome of the study and 
it was demonstrated to be significantly 
improved only in the US-guided injec-
tion group, with a significant statistical 
difference between the two groups. 
Lee et al. studied the efficacy of US-
guided intra-articular injections com-
pared with the blind approach for the 
treatment of adhesive capsulitis (18). 
In this RCT, forty-three patients were 
enrolled after clinical radiologic exami-
nations and US study confirming the 
presence of adhesive capsulitis. Forty 
patients completed the study. All the 
patients received a CS intra-articular 
injection mixed with lidocaine and nor-
mal saline, followed by 5 weekly injec-
tions of HA. The main outcome meas-
ures were: pain intensity (VAS), ROM 
(shoulder flexion, abduction, external 
rotation, and internal rotation) and 
general shoulder function during daily 
activities at every week after injection 
for 6 weeks. Injections were made us-
ing a posterior approach in both groups. 
A statistically significant improvement 
was demonstrated in pain intensity in 
the first two weeks in the US-guided 
injection group; no further significant 
differences were noted beyond the third 
week. Internal rotation ROM improved 
significantly in the US-guided group 
up to the fourth week, after which no 
differences were noted between the 
groups. Shoulder function score im-
provement was significantly higher in 
the US-guided group for the first three 
weeks. So, apparently, the US-guided 
group had significantly better results 
than the other one in all of the three 
outcomes at the first week, when only 
CS were used.
More recently, Zufferey et al. compared 
US-guided with standard injection for 
the management of acute painful shoul-
Fig. 1. flow chart showing the selection process.
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der (20). Seventy patients were as-
sessed clinically and by US. Blind ap-
proach was directed to the subacromial 
bursa while US-guided injections were 
directed into the location assessed by 
US as the cause of shoulder pain. The 
primary outcome was pain (assessed 
as vocal numerical rating scale (NRS) 
ranging from 0 to 10) at 2 and 6 weeks, 
and function (shoulder ROM and Con-
stant score) at 6 weeks. The US injec-
tion group showed a significant reduc-
tion in night pain at 2 and 6 weeks (and 
it was the same for the number of good 
responders). In this study, the patients 
were screened and enrolled at two dif-
ferent centres, using different US ma-
chines, and using a scanning protocol 
that could be not optimal (minimum of 
six different views). 
Short-term response to CS injection in 
subacromial impingement syndrome 
has been investigated by Dogu et al. 
(21), who compared the efficacy of a 
blind or US-guided approach. Forty-
six patients were enrolled in this RCT 
to US-guided (group 1) or blind CS in-
jections (group 2). MRI was used to as-
sess whether the injection reached the 
subacromial space (every injection also 
contained gadolinium). No statistically 
significant difference was found in the 
accuracy of the injection location be-
tween the two groups (accurate injec-
tions were performed in 65% of pa-
tients in group 1 and 70% in group 2), 
nor were there any differences in im-
provement of the pain and functional 
status of the patients between the two 
groups. The problem with this study is 
that the approach of the injection was 
different (posterior for the blind group 
and lateral for the US guided group) 
and, in any case, the blind injections 
were not completely blind, but US-
assisted. Besides, the diagnosis leaves 
some doubts: the definitions of bursi-
tis and tenosynovitis were given even 
in the presence of a tear of the rotator 
cuff and, obviously, the efficacy of CS 
could be different with respect to the 
presence of an inflammation or a ten-
don tear.
Is a US-guided approach useful 
when injecting CS in the shoulder?
The published literature does not pro-
vide enough data to assess whether US-
guided injections are more efficient in 
controlling shoulder pain with respect 
to the landmark approach. The two tech-
niques are frequently not really compa-
rable in the studies because not all of the 
anatomical structures can be reached 
using a lateral approach so, using dif-
ferent approaches (due to the different 
diseases) might not be appropriate from 
a methodological point of view. At the 
same time, effusion in the subacromial 
bursa could be due to either inflamma-
tion or secondary to rotator cuff disease; 
in this case, the effectiveness of CS in-
jection could be different not only be-
cause of the different approach, but also 
because of the different pathogenesis.
What is likely to be true is the fact that 
US-guided technique shows a more 
rapid improvement, at least in some 
specific diseases (i.e. adhesive capsu-
litis). A possible explanation is that a 
greater anti-inflammatory effect may 
be achieved using the US-guided ap-
proach because of the higher CS vol-
ume injected right where it is needed. 
In 1997, Eustace et al. (11) demonstrat-
ed that an accurate injection improved 
shoulder function in patients with im-
pingement syndrome. It is also true 
that, after a few days/weeks, CS may 
diffuse in the soft tissue and provide a 
beneficial effect independently of the 
initial location.  
Finally, Sibbit et al. (22) found that US-
guided injections not only improved 
clinical outcomes, but were also more 
cost-effective in inflammatory arthritis.
HA injection
Few papers have been published on the 
use of HA in the viscosupplementation 
of the shoulder for osteoarthritis (23-
27), however, only a few authors have 
explored the field of HA shoulder injec-
tion using a US-guided approach (29). 
Tagliafico et al. (28) first assessed 
whether US-guided viscosupplemen-
tation plus capsular distension could 
reduce pain and improve function 
in elderly patients with cuff tear ar-
thropathy. A group of ninety-three 
patients aged over 65 years old, with 
massive rotator cuff tear were includ-
ed in the prospective open-label non-
randomised trial. Thirty-three patients 
received one US-guided intra-articular 
injection of high molecular weight HA 
a week for two weeks, while the rest 
of the patients were considered as a 
control group. The Constant scores 
(for function) and VAS (for pain) were 
monthly outcomes up to six months. 
Patients treated with HA reported a sig-
nificant decrease in VAS and Constant 
score every month, up to the fourth. 
After five months there were no differ-
ences between the two groups.  
More recently, Park et al. in a prospec-
tive RCT, investigated the efficacy of 
US-guided intra-articular HA injection 
plus capsular distension, comparing it 
to the CS injection alone in patients 
with adhesive capsulitis of the shoul-
der. Ninety patients were assigned to 
the two groups: 45 patients in group 
A (treated with lidocaine + CS) and 45 
patients in group B (treated with lido-
caine plus HA and capsular distension) 
(29). All injections were performed 
every 2 weeks for a total of 3 times, us-
ing a posterior approach. The main out-
comes were pain relief (VNS), func-
tional improvement (Shoulder Pain and 
Disability Index (SPADI)) and passive 
ROM of the shoulder (flexion, abduc-
tion, external rotation) at 2 and 6 weeks 
after the last injections. All of the out-
comes improved in both groups, how-
ever, only shoulder passive external ro-
tation was significantly more improved 
in group B (both at 2 and 6 weeks).
Is US-guided approach useful 
when injecting HA in the shoulder?
Intra-articular HA injection represents 
a treatment option in the management 
of adhesive capsulitis of the shoulder, 
however its effect remains controver-
sial. We know that, unlike steroids, 
HA cannot spread in the anatomic area 
providing efficacy when the target is 
not completely reached (30). Besides, 
incorrect placement can cause discom-
fort (24) so a more accurate injection 
using US guidance (and concurrent 
capsular distension) might be useful to 
improve the efficacy of such treatment. 
Unfortunately, nowadays, there are no 
studies comparing the blind approach 
to the US-guided one.  However, we 
suppose that the US-guided technique 
has to become more and more used. 
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Injection of other substances 
In 2010 Hashiuchi et al. (31), compared 
the efficacy of lidocaine injection when 
performed US-guided or blind. The 
study was carried out on 16 patients (20 
shoulder), treated firstly using the US-
guided technique and, one week later, 
the blind approach. To inject the subac-
romial bursa an antero-lateral approach 
was used for all the injections. Pain 
score, registered every 5 minutes for 
half an hour after the injection, was the 
primary outcome and significant differ-
ences, in favour of the US-guided injec-
tion, were registered at all time points. 
Fifteen out of the sixteen patients pre-
ferred the US-guided technique.
In the chronic stage of the impingement 
syndrome, tendons present changes de-
scribed as tendinosis, similar to what 
is found in chronic painful Achilles 
and patellar tendons. A vasculo-neu-
ral ingrowth has been shown in those 
disorders and it seems to be related to 
pain. Previous studies demonstrated 
good short-term clinical effects with 
injections of the sclerosing substance 
polidocanol in chronic painful Achil-
les and patellar tendinopathy (32-34). 
Based on those data, Alfredson et al. 
treated 15 patients with a long duration 
of shoulder pain due to chronic painful 
shoulder impingement syndrome (35). 
Vascularity (neovessels) was found 
only in chronic painful supraspinatus 
tendons, and a US-guided injection of 
polidocanol was made, targeting the 
area with neovessels. The outcome was 
shoulder pain (VAS) after the injection 
and the patient’s satisfaction was also 
assessed. Two (median; range 1–5) po-
lidocanol treatments (with an interval 
of 4–8 weeks) were given. At follow-
up, 8 (median; range 4–17) months af-
ter treatment, 14 patients were satisfied 
with the result and VAS was significant-
ly reduced. 
Another treatment proposed for the 
rotator cuff disease treatment is plate-
let-rich plasma (PRP) injection. This 
substance is expected to facilitate the 
healing of structures with poor vascu-
larisation. Rha et al. (36) compared the 
efficacy of two PRP injections to two 
dry needling (or percutaneous micro-
tenotomy) techniques; the last one is 
used to treat a chronic tendon injury 
trying to change a chronic non-healing 
injury into an acute lesion with a po-
tentially greater healing possibility. 
Thirty-nine patients with chronic pain 
due to supraspinatus tendon disease 
(tendinosis or little partial-thickness 
tear) were enrolled in the study and al-
located to PRP injection or dry needle 
technique. The main outcome was the 
Shoulder Pain and Disability Index 
score (SPDI), which decreased in both 
arms of the study. For two weeks after 
the second injection, up to 6 months, 
the PRP group had a significantly bet-
ter improvement of SPDI; internal 
rotation and flexion were also signifi-
cantly improved in the PRP group at 
the three-month (both) and six-month 
(flexion only) follow-up visit.
Finally, we report the use of botulinum 
toxintype B (BT) for subacromial bur-
sitis or impingement syndrome. Lee et 
al. recently compared BT to CS. Sixty-
one patients were divided into 2 groups 
and treated with BT type B (BT group) 
or trimacinolone injection (TA group) 
using a US-guided approach  (37). The 
outcomes considered were pain (NRS), 
active shoulder abduction angle, and 
the Disability of Arm, Shoulder, and 
Hand (DASH) score at 1 and 3 months 
after the treatment. Both groups im-
proved in all of the outcomes and the 
BT group showed significantly better 
results on NRS and DASH at 3 months 
with respect to the TA group. No dif-
ferences between the two groups were 
found after 1 month. 
A similar study has recently been made 
by Joo et al., but the use of BT type A 
failed to be superior with respect to CS, 
demonstrating similar efficacy (38).
Is US-guided approach useful 
when injecting other substances 
in the shoulder?
The few patients treated and the meth-
odology of the studies preclude reach-
ing any final conclusion, however, 
these new treatments for shoulder pain 
could be interesting but still need future 
validation in more appropriate RCTs.
Key messages
• The literature is not unequivocal in 
supporting the fact that the US-guid-
ed approach provides better results 
than the blinded procedures (espe-
cially for soluble drugs such as CS) 
• US-guided technique could repre-
sent an improvement in efficacy of 
injections for shoulder pain, mainly 
because it is more accurate in reach-
ing the target, particularly for some 
specific sites and using specific 
medications (i.e. HA)
• US-guided technique provides the 
most suitable insertion for both the 
patient and the operator, determines 
a greater safety, and could reduce 
the risks (i.e. neuro-vascular bundle 
contact or intramuscular injections) 
and the patient’s discomfort 
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